-
Recent Posts
- Five People Injured on Highway 49 Crash
- FDA Safety Warning For Multaq, A Heart Rhythm Drug
- About 6,800 Naturalizer Women’s Shoes Recalled
- Pampered Chef Ice Cream Scoops Recalled
- Self-Awareness Exercises Found to Decrease Fibromyalgia Pain
- Physical Therapy Not Only for Rehabilitation
- Bears’ Receiver Faces 4 Months of Recovery
- About 21,600 Honda Goldwing Motorcycles Recalled
- DUI Suspect Collides Head-On With Vehicle
- Fatal Highway 101 Crash Leaves One Dead, One Injured
Tag Archives: drug
FDA Safety Warning For Multaq, A Heart Rhythm Drug
According to news sources , the drug Multaq is getting a new safety warning after a study found increased risks of heart attack, stroke and death associated with the drug with a subset of patients that took part in the study. The heart rhythm drug controls the heart’s chambers by allowing them to pump in sync for patients with atrial fibrillation. The new warning would allow the drug to remain on the market but would stress to doctors and patients that it be used only for treatment of the short-term variant of the condition Continue reading
Weight-Loss Drug Warning Issued
Customers are being advised to avoid a weight-loss drug called human chorionic gonadotropin due to the drug not being approved by the FDA. Warning letters were issued by the Federal Trade Commission and FDA to companies that market the product for weight loss Continue reading
FDA Revokes Approval of Breast Cancer Drug Avastin
According to news sources , the Food and Drug Administration has revoked a previous approval to give Avastin market access to breast cancer patients through its accelerated approval program. The program allows the FDA to revoke drug approvals if clinical trials do not show drug effectiveness. The FDA’s accelerated program allows drugs to gain market access to patients while clinical trials are ongoing. Continue reading
FDA to Review Fosamax
On Friday, September 9, two panels of the United States Food and Drug Administration will meet to discuss the drug Fosamax and its long term use, and whether the drug should have time restrictions placed on its usage, requiring users to stop using it for certain lengths of time during treatment, according to news reports . A study that suggested bisphosphonate drugs like Fosamax increases the users risk of suffering femur fractures was released in July, which prompted this safety review Continue reading
Posted in Personal Injury, Product Liability, Safety, Uncategorized
Tagged drug, fosamax, fosamax lawsuit, injured-because, product liability, research, safety, warn-consumers
Leave a comment